Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001933562 | SCV002205187 | uncertain significance | not provided | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005350766 | SCV006009342 | uncertain significance | Inborn genetic diseases | 2025-01-31 | criteria provided, single submitter | clinical testing | The c.496A>G (p.M166V) alteration is located in exon 4 (coding exon 4) of the GPX4 gene. This alteration results from a A to G substitution at nucleotide position 496, causing the methionine (M) at amino acid position 166 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |